Lung Cancer
Volume 55, Issue 1 , Pages 61-66 , January 2007

Evaluation of extratumoral lymphatic permeation in non-small cell lung cancer as a means of predicting outcome

  • Takamoto Saijo

      Affiliations

    • Division of Thoracic Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, Japan
    • Pathology Division, Research Center for Innovative Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
    • Corresponding Author InformationCorresponding author at: Division of Thoracic Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba 277-8577, Japan. Tel.: +81 471 33 1111; fax: +81 471 31 4724.
    • ,
  • Genichiro Ishii

      Affiliations

    • Pathology Division, Research Center for Innovative Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
    • ,
  • Atsushi Ochiai

      Affiliations

    • Pathology Division, Research Center for Innovative Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
    • ,
  • Takahiro Hasebe

      Affiliations

    • Pathology Division, Research Center for Innovative Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
    • ,
  • Junji Yoshida

      Affiliations

    • Division of Thoracic Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, Japan
    • ,
  • Mitsuyo Nishimura

      Affiliations

    • Division of Thoracic Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, Japan
    • ,
  • Kanji Nagai

      Affiliations

    • Division of Thoracic Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, Japan

Received 10 March 2006 ,Revised 2 August 2006 ,Accepted 25 September 2006.

References 

  1. Suzuki K, Nagai K, Yoshida J, Nishimura M, Takahashi K, Yokose T, et al. Conventional clinicopathologic prognostic factors in surgically resected nonsmall cell lung carcinoma. Cancer. 1999;86:1976–1984
  2. Poleri C, Morero JL, Nieva B, Vazquez MF, Rodgriguez C, de Titto E, et al. Risk of recurrence in patients with surgically resected stage I non-small cell lung carcinoma. Chest. 2003;123:1858–1867
  3. Bréchot J-M, Chevret S, Charpentier M-C, de Vecchi CA, Capron F, Prudent J, et al. Blood vessel and lymphatic vessel invasion in resected nonsmall cell lung carcinoma. Cancer. 1996;78:2111–2118
  4. Paolo M, Gabriella F, Michael H, Hsu C, Daniela B, Silvana V, et al. Blood vessel invasion by tumor cells predicts recurrence in completely resected T1 N0 M0 non-small cell lung cancer. J Thorac Cardiovasc Surg. 1993;106:80–89
  5. Roberts TE, Hasleton PS, Musgrove C, Swindell R, Lawson RAM. Vascular invasion in non-small cell lung carcinoma. J Clin Pathol. 1992;45:591–593
  6. Rigau V, Molina TJ, Chaffaud C, Huchon G, Audouin J, Chevret S, et al. Blood vessel invasion in resected non small cell lung carcinoma is predictive of metastatic occurrence. Lung Cancer. 2002;38:169–176
  7. Gabor S, Renner H, Popper H, Anegg U, Sankin O, Matzi V, et al. Invasion of blood vessels as significant prognostic factor in radically resected T1-3N0M0 non-small-cell lung cancer. Eur J Cardio-thorac Surg. 2004;25:439–442
  8. Hasebe T, Sasaki S, Imoto S, Ochiai A. Characteristics of tumors in lymph vessels play an important role in the tumor progression of invasive ductal carcinoma of the breast. Mod Pathol. 2002;15:904–913
  9. Hasebe T, Sasaki S, Imoto S, Ochiai A. Histological characteristics of tumor in vessels and lymph nodes are significant predictors of progression of invasive ductal carcinoma of the breast. Hum Pathol. 2004;35:298–308
  10. Sakuragi N, Takeda N, Hareyama H, Fujimoto T, Todo Y, Okamoto K, et al. A multivariate analysis of blood vessel and lymph vessel invasion as predictors of ovarian and lymph node metastases in patients with cervical carcinoma. Cancer. 2000;88:2578–2583
  11. Creasman WT, Kohler MF. Is lymph vascular space involvement an independent prognostic factor in early cervical cancer?. Gynecol Oncol. 2004;92:525–529
  12. Shields Thomas W. Prognostic significance of parenchymal lymphatic vessel and blood vessel invasion in carcinoma of the lung. Surg Gynecol and Obstet. 1983;157:185–190
  13. Fujisawa T, Yamaguchi Y, Saitoh Y, Hiroshima K, Ohwada H. Blood and lymphatic vessel invasion as prognostic factors for patients with primary resected nonsmall cell carcinoma of the lung with intrapulmonary metastases. Cancer. 1995;76:2464–2470
  14. Paolo M, Gabriella F, James H, Raffaele P, C. Alberto A, et al. Most peripheral, node negative, non-small cell lung cancers have low proliferative and no intratumoral and peritumoral blood and lymphatic vessel invasion. J Thorac Cardiovasc Surg. 1992;104:892–899
  15. Goto K, Yokose T, Mukai K, Ochiai A. Detection of early invasion on the basis of basement membrane destruction in small adenocarcinomas of the lung and its clinical implications. Mod Pathol. 2001;14:1237–1245
  16. Funai K, Yokose T, Nishiwaki Y, Ochiai A. Clinicopathologic characteristics of peripheral squamous cell carcinoma of the lung. Am J Surg Pathol. 2003;27:978–984
  17. Padera TP, Kadambi A, di Tomaso E, Carreira CM, Brown EB, Boucher Y, et al. Lymphatic metastasis in the absence of functional intratumor lymphatics. Science. 2002;296:1883–1886

PII: S0169-5002(06)00526-5

doi: 10.1016/j.lungcan.2006.09.027

Lung Cancer
Volume 55, Issue 1 , Pages 61-66 , January 2007

Article Tools

* Image Usage & Resolution